चार शहरों में 18-50 वर्ष के आयु वर्ग में किए गए एक विशेष अध्ययन से पता चला है कि 44 प्रतिशत शहरी लोगों ने कोविड के समय में नाश्ता नहीं किया है। यह अध्ययन मार्च 2020 और फरवरी 2021 के बीच लंदन स्थित बाजार अनुसंधान प्रमुख यूरोमॉनिटर इंटरनेशनल और पेप्सिको इंडिया द्वारा अपने ब्रांड क्वेकर के माध्यम से किया गया था।
एक आधिकारिक विज्ञप्ति के अनुसार, अध्ययन में इस बात पर प्रकाश डाला गया कि 44 प्रतिशत शहरी लोगों ने घर के कामों में वृद्धि और दिन की शुरूआत में देरी के कारण नाश्ता करना छोड़ दिया था और भोजन करने में भी देरी की।
इसके अलावा, 64 प्रतिशत शहरी मिलेनियल्स उत्तरदाताओं को एक स्वस्थ प्रतिरक्षा प्रणाली की ओर प्रेरित किया गया था।
अध्ययन में आगे बताया गया है कि जई सहित फलों, सब्जियों और साबुत अनाज की बढ़ती खपत महामारी के दौरान प्रमुख प्रवृत्ति के रूप में उभरी।
दिल्ली, मुंबई, बैंगलोर और कोलकाता में शहरी मिलेनियल्स पर ध्यान केंद्रित करते हुए, कोविड-19 के बाद शहरी भारतीय उपभोक्ताओं की बदलती जीवनशैली और आहार संबंधी आदतों को लेकर अध्ययन में 18-50 वर्ष के आयु वर्ग के 1,000 उत्तरदाताओं को शामिल किया गया था।
अध्ययन में उपभोक्ता व्यवहार को समझने के लिए कोविड के बाद लोगों की बदलती जीवन शैली और आहार पैटर्न का विश्लेषण किया गया।
इसने एक बदलते पैटर्न को, विशेष रूप से शहरी मिलेनियल्स के बीच एक स्वस्थ प्रतिरक्षा प्रणाली और वजन बनाए रखने के लिए आहार संबंधी आदतों के प्रति ट्रैक किया।
अध्ययन ने यह भी मैप किया कि क्या भविष्य में बदले हुए व्यवहार बने रहेंगे और इस तथ्य को रेखांकित किया कि वजन पर नजर रखने वालों को समय पर भोजन करने और पोषक तत्वों से भरपूर नाश्ते के महत्व को समझना चाहिए।
इसके अलावा, यह पाया गया कि 71 प्रतिशत शहरी मिलेनियल्स ने वजन बनाए रखने के लिए कीटो, आंतरायिक उपवास और साप्ताहिक डिटॉक्स योजना सहित सनक आहार की लोकप्रियता की ओर झुकाव किया।
यूरोमॉनिटर इंटरनेशनल की सलाहकार विधि शर्मा ने कहा कि मिलेनियल्स नाश्ते के महत्व को स्वीकार करते हैं और मानते हैं कि इसमें पौष्टिक पोषण होना चाहिए, वे अक्सर अपने काम के शेड्यूल के कारण नाश्ता छोड़ देते हैं या सुबह जल्दी नाश्ता कर लेते हैं।
अध्ययन के निष्कर्षों के बारे में बात करते हुए, सोनम विज, एसोसिएट डायरेक्टर और कैटेगरी लीड, क्वेकर पोर्टफोलियो, पेप्सिको इंडिया ने कहा कि शहरी मिलेनियल्स अब तेजी से अपने शारीरिक और मानसिक स्वास्थ्य में सुधार पर ध्यान केंद्रित कर रहे हैं जो एक सक्रिय जीवन शैली का गठन करता है। (एजेंसी)
यह भी पढ़े► स्लीप एपनिया सिंड्रोम से भारत में 40 लाख लोग प्रभावित
New Delhi, Aug 15 (IANS) As India has stepped into the 75th year of Independence with the looming threat of third Covid wave, Dr. MC Mishra, former Director at AIIMS, holds less expenditure on health as a big hurdle in providing quality treatment to all across the nation.Talking to IANS, Dr Mishra said: "We are spending slightly more than one per cent of GDP in healthcare while European nations like United Kingdom, Netherlands, New Zealand, and others spend over 9 per cent of their total GDP in public healthcare system. Spending optimum amount can only ensure total public health." He said that India has advanced towards public health in these 74 years of post-independence, but the primary health sector still needs to be addressed more efficiently."If we are hoping to lessen the burdens of the secondary and tertiary sector, the government has to strengthen the primary health sector in the rural area to provide quality healthcare at the doorstep," added Dr. Mishra.On the proportion of the Doctor and Patient ratio, he opined to inculcate other traditional healthcare systems of India also while calculating the number. He said, "We should include the Allopathy, Homeopathy and Ayush Doctors together as they are also serving and provide treatment at primary levels." He opined to cover all prevalent systems of health care in a single ambit.Being asked about India's healthcare system during pandemic, he said India has managed the pandemic and the public-private partnership in providing better healthcare should continue beyond the pandemic, taking care of affordability issues for the common man where the government can intervene.Deliberating on challenges, he added that affordability is a major concern for the common folk in private hospitals but the government should prepare a mechanism to address this issue for public health.--IANSavr/pgh
Tokyo - Researchers have found that a fermented soybean dish often served for breakfast in Japan, can prove to be effective against SARS-CoV-2, the virus that causes Covid-19.
Natto is made by fermenting soybeans with Bacillus subtilis, a bacteria found in plants and in soil.
Researchers from the Tokyo University of Agriculture and Technology (TUAT) found that the extract made from the sticky, strong smelling natto may inhibit the ability of the SARS-CoV-2 virus to infect cells.
"Traditionally, Japanese people have assumed that natto is beneficial for their health," said Tetsuya Mizutani, director of the Center for Infectious Disease Epidemiology and Prevention Research at the TUAT.
"In recent years, research studies have revealed scientific evidence for this belief. In this study, we investigated natto's antiviral effects on SARS-CoV-2, the virus that causes Covid-19, and bovine herpesvirus 1 (BHV-1), which causes respiratory disease in cattle," Mizutani added.
The findings were published in the journal Biochemical and Biophysical Research Communications.
The team prepared two natto extracts from the food, one with heat and one without. They applied the extracts to sets of lab-cultured cells from cattle and from humans. One set was infected with SARS-CoV-2, while the other set was infected with BHV-1.
When treated with the natto extract made without heat, both SARS-CoV-2 and BHV-1 lost the ability to infect cells. However, neither virus appeared to be affected by the heat-treated natto extract.
"We found what appears to be a protease or proteases -- proteins that metabolise other proteins -- in the natto extract directly digests the receptor binding domain on the spike protein in SARS-CoV-2," Mizutani said, noting that the protease appears to break down in heat, losing the ability to digest proteins and letting the virus remain infectious.
The spike protein sits on the virus's surface and binds to a receptor on host cells. With an inactive spike protein, SARS-CoV-2 cannot infect healthy cells. The researchers found a similar effect on BHV-1 as well as the Alpha Covid variant.
While the results are promising, Mizutani also cautioned that further studies are needed to identify the exact molecular mechanisms at work. He also stressed that the research does not provide any evidence of reduced viral infection simply by eating natto. Once the components are identified and their functions verified, the researchers plan to advance their work to clinical studies in animal models. (IANS)
<br>"Modern technology companies have enabled misinformation to poison our information environment with little accountability to their users", Murthy said at a White House briefing on Thursday. "We are asking them to step up, we can't wait longer for them to take aggressive action."Murthy on Thursday released a 22-page advisory highlighting a string of false claims that have driven people away from vaccines at a time when the pace of Covid-19 vaccinations has slowed throughout the US.Murthy's advisory lists recommendations across eight stakeholder groups. It calls on teachers to focus on media literacy, it asks journalists to debunk health misinformation without spreading it further. Murthy asks doctors to "listen with empathy, and when possible, correct misinformation in personalized ways.""Misinformation poses an imminent and insidious threat to our nation's health," Murthy said. "We must confront misinformation as a nation. Lives are depending on it."Striking a personal note, Murthy said he is "concerned" as a father of two young children who aren't yet eligible for the vaccine. Murthy said he has lost 10 family members to Covid-19 and wishes "each and every day" that they had had the opportunity to get vaccinated.Murthy is calling for a national effort across tech companies, health care workers, journalists and everyday Americans to do more to address an "urgent threat" to public health.The US has one of the highest vaccination rates in the world and yet, new Covid-19 infections have doubled over the past two weeks. CNN reported on Thursday that cases are rising in 47 states.ALos Angeles County, the most populous county in the US, reported its fifth straight day this week of more than 1,000 new cases.The US continues to have the world's highest Covid-19 toll. The virus has killed more than 608,000 in this country alone since it first arrived on the West Coast in January 2020.--IANS<br>nik/pgh<br>
New Delhi, July 9 (IANS) A total of 56 restaurants and eateries in South Delhi can serve food and beverages in open-air spaces and terraces, a decision in this regard was taken by South Delhi Municipal Corporation (SDMC).However, the permission to serve food and liquor in open space is permitted to those restaurants which have obtained permission from the civic authority after fulfilling certain criteria.A senior official privy with the development told IANS that as of now 56 restaurants have been permitted to serve food and beverages in open spaces like terraces. The proposal for permitting liquors and foods in open-air space with certain regulations was made by SDMC last year and the applications were invited to get permission.Out of total, as many as 39 applications were received from areas in the South zone which includes -- Hauz Khas, Green Park and Greater Kailash. Similarly, a total of 31 applications were received from Najafgarh zone, which comprises areas such as Dwarka and Aerocity.Fifteen applications were received from areas in the Central zone like Lajpat Nagar, Bhogal and Defence Colony. Nine applications were received from Western zone areas like Punjabi Bagh, Rajouri Garden and Tilak Nagar.As many as 23 licenses were granted in the South zone, 25 in Najafgarh and seven in the Central zone. Only one was granted a licence for open-air dining in the West zone.The SDMC had passed the proposal last year in view of Covid-19 pandemic in which the restaurants would be allowed to use open-air spaces and terraces abutting licensed eateries as service areas.Under the policy, open-air dining has been allowed only at those restaurants with privately-owned open spaces like terraces, balconies and lawns so that there is no encroachment on public land or pavements."Serving food and alcohol will be permitted in the open space, and the open-air area/terrace should not be covered. If the open space is visible from nearby residential premises, then additional measures to be taken to obstruct visibility," SDMC's proposal states.It also made it clear that the service area should also not be visible from adjoining residential areas. Live performances will not be allowed and music cannot be played beyond the permissible time of 11 p.m.The official said in the last nine months (till June-end), the civic body received 94 applications, out of which 56 were granted licences and 28 were rejected for not fulfilling the norms.SDMC Mayor Mukesh Suryan talking to IANS said, "For the past few years there has been consistent demand from the people in South Delhi to allow serving liquors and foods in open-air space and it has been done considering the demand of people. The step will also help to maintain social distancing during this Covid-19 pandemic."Suryan further added that as of now only 56 restaurants have been granted permission but this number can increase in the coming days if the applicants (restaurants and eateries owners) meet the certain rules.--IANSpd/dpb
Hyderabad, July 1 (IANS) Sputnik Light, the single-dose Covid-19 vaccine, can submit Russian safety data for approval in India, Dr Reddy's Laboratories said on Thursday.The Hyderabad-based Dr Reddy's, in a statement, said that the Subject Expert Committee (SEC) under Drugs Controller General of India (DCGI) asked it to submit safety, immunogenicity and efficacy data from the Phase 3 clinical trial of Sputnik Light in Russia for consideration of marketing authorisation of Sputnik Light in India.The SEC, at its meeting on Wednesday, deliberated on the submission for marketing authorisation of Sputnik Light from Dr Reddy's. The company presented to the SEC, interim safety and efficacy data from the Phase 1/2 clinical trial of Sputnik Light in Russia, along with a clinical trial protocol for a Phase 3 trial of Sputnik Light in India.The SEC made the recommendation in view of the fact that Sputnik Light is the first dose component of Sputnik V, and Dr Reddy's has already generated safety and immunogenicity data on the first dose component in India through its clinical trial and a Phase 3 efficacy trial is currently underway in Russia on Sputnik Light."Further, the SEC also observed that in view of the safety and immunogenicity data already generated by Dr Reddy's in India on the first dose component of Sputnik V (in other words, Sputnik Light), there was no need for a separate Phase 3 trial of Sputnik Light in India," the statement said.Sputnik Light is a single dose Covid-19 vaccine from the makers of Sputnik V and is yet to be approved in India.--IANSms/vd